4.4 Review

Use of Lactobacilli and their Pheromone-Based Regulatory Mechanism in Gene Expression and Drug Delivery

期刊

CURRENT PHARMACEUTICAL BIOTECHNOLOGY
卷 10, 期 1, 页码 62-73

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920109787048571

关键词

Lactic acid bacteria; lactobacilli; pSIP vectors; bacteriocins; gene expression; protein delivery

资金

  1. Research Council of Norway

向作者/读者索取更多资源

Lactobacilli are common microorganisms in diverse vegetables and meat products and several of these are also indigenous inhabitants in the gastro-intestinal (GI) tract of humans and animals where they are believed to have health promoting effects on the host. One of the highly appreciated probiotic effects is their ability to inhibit the growth of pathogens by producing antimicrobial peptides, so-called bacteriocins. Production of some bacteriocins has been shown to be strictly regulated through a quorum-sensing based mechanism mediated by a secreted peptide-pheromone (also called induction peptide; IP), a membrane-located sensor (histidine protein kinase; HPK) and a cytoplasmic response regulator (RR). The interaction between an IP and its sensor, which is highly specific, leads to activation of the cognate RR which in turn binds to regulated promoters and activates gene expression. The HPKs and RRs are built up by conserved modules, and the signalling between them within a network is efficient and directional, and can easily be activated by exogenously added synthetic IPs. Consequently, components from such regulatory networks have successfully been exploited in construction of a number of inducible gene expression systems. In this review, we discuss some well-characterised quorum sensing networks involved in bacteriocin production in lactobacilli, with special focus on the use of the regulatory components in gene expression and on lactobacilli as potential delivery vehicle for therapeutic and vaccine purposes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pediatrics

Experimental support for multidrug resistance transfer potential in the preterm infant gut microbiota

Mari Hagbo, Anuradha Ravi, Inga Leena Angell, Marianne Sunde, Jane Ludvigsen, Dzung B. Diep, Steven L. Foley, Maximo Vento, Maria Carmen Collado, Gaspar Perez-Martinez, Knut Rudi

PEDIATRIC RESEARCH (2020)

Review Engineering, Biomedical

Topical antimicrobial peptide formulations for wound healing: Current developments and future prospects

Raj Kumar Thapa, Dzung B. Diep, Hanne Hjorth Tonnesen

ACTA BIOMATERIALIA (2020)

Article Multidisciplinary Sciences

Biochemical, genetic and transcriptional characterization of multibacteriocin production by the anti-pneumococcal dairy strain Streptococcus infantarius LP90

Cristina Campanero, Estefania Munoz-Atienza, Dzung B. Diep, Javier Feito, Sara Arbulu, Rosa del Campo, Ingolf F. Nes, Pablo E. Hernandez, Carmen Herranz, Luis M. Cintas

PLOS ONE (2020)

Article Pharmacology & Pharmacy

Preformulation studies on novel garvicin KS peptides for topical applications

Raj Kumar Thapa, Hanne Cecilie Winther-Larsen, Dzung B. Diep, Hanne Hjorth Tonnesen

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Microbiology

Successful Development of Bacteriocins into Therapeutic Formulation for Treatment of MRSA Skin Infection in a Murine Model

Kirill Ovchinnikov, Christian Kranjec, Tage Thorstensen, Harald Carlsen, Dzung B. Diep

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Biotechnology & Applied Microbiology

A bacteriocin-based antimicrobial formulation to effectively disrupt the cell viability of methicillin-resistant Staphylococcus aureus (MRSA) biofilms

Christian Kranjec, Kirill V. Ovchinnikov, Torstein Gronseth, Kumar Ebineshan, Aparna Srikantam, Dzung B. Diep

NPJ BIOFILMS AND MICROBIOMES (2020)

Article Pharmacology & Pharmacy

Photostability studies of GarKS peptides for topical formulation development

Raj Kumar Thapa, Hanne Cecilie Winther-Larsen, Dzung B. Diep, Hanne Hjorth Tonnesen

Summary: The study revealed that combinations such as GakA+GakB exhibited the highest photostability, while GakA+GakB+GakC combination enhanced stability under indoor conditions but reduced under outdoor conditions. Adding antioxidants like glutathione or scavengers like trehalose improved the photostability of peptides.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Article Microbiology

Exploring the Therapeutic Potenital of the Leaderless Enterocins K1 and EJ97 in the Treatment of Vancomycin-Resistant Enterococcal Infection

Ingvild Reinseth, Hanne H. Tonnesen, Harald Carlsen, Dzung B. Diep

Summary: The membrane-bound protease Eep is a crucial virulence factor in pathogenic enterococci, involved in stress response and serving as a receptor for bacteriocins. The bacteriocins have potential for treating VRE infections due to their dual function targeting wildtype enterococcal cells and reducing virulence in bacteriocin-resistant mutants.

FRONTIERS IN MICROBIOLOGY (2021)

Review Infectious Diseases

Staphylococcal Biofilms: Challenges and Novel Therapeutic Perspectives

Christian Kranjec, Danae Morales Angeles, Marita Torrissen Marli, Lucia Fernandez, Pilar Garcia, Morten Kjos, Dzung B. Diep

Summary: This article outlines the mechanisms by which staphylococci form biofilms and the challenges in eradicating them, highlighting the need for new treatment strategies. It also explores promising therapeutic approaches such as bacteriocins and phage-derived anti-biofilm methods.

ANTIBIOTICS-BASEL (2021)

Article Microbiology

Lactococcus lactis Resistance to Aureocin A53-and Enterocin L50-Like Bacteriocins and Membrane-Targeting Peptide Antibiotics Relies on the YsaCB-KinG-LlrG Four-Component System

Aleksandra Tymoszewska, Kirill Ovchinnikov, Dzung B. Diep, Malgorzata Slodownik, Edyta Maron, Beatriz Martinez, Tamara Aleksandrzak-Piekarczyk

Summary: Resistance of Lactococcus lactis to aureocin A53- and enterocin L50-like bacteriocins is associated with mutations in genes encoding ABC transporter and TCS, leading to upregulation of other operons. Protein modification, rather than absence, is critical for the development of resistance to bacteriocins.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Multidisciplinary Sciences

A bacteriocin-based treatment option for Staphylococcus haemolyticus biofilms

Christian Kranjec, Sofie S. Kristensen, Karolina T. Bartkiewicz, Mikkel Bronner, Jorunn P. Cavanagh, Aparna Srikantam, Geir Mathiesen, Dzung B. Diep

Summary: A novel hybrid bacteriocin H1 showed superior antimicrobial effects against Staphylococcus haemolyticus and high activity towards various strains without strain-dependency. Combination with broad-spectrum bacteriocins micrococcin P1 and garvicin KS effectively eradicated biofilm-associated cells and prevented development of resistant mutants, indicating its potential as a treatment option for S. haemolyticus.

SCIENTIFIC REPORTS (2021)

Correction Biotechnology & Applied Microbiology

The Increasing Issue of Vancomycin-Resistant Enterococci and the Bacteriocin Solution (vol 12, pg 1203, 2020)

Ingvild S. Reinseth, Kirill V. Ovchinnikov, Hanne H. Tonnesen, Harald Carlsen, Dzung B. Diep

PROBIOTICS AND ANTIMICROBIAL PROTEINS (2022)

Article Microbiology

Ubericin K, a New Pore-Forming Bacteriocin Targeting mannose-PTS

Thomas F. Oftedal, Kirill Ovchinnikov, Kai A. Hestad, Oliver Goldbeck, Davide Porcellato, Judith Narvhus, Christian U. Riedel, Morten Kjos, Dzung B. Diep

Summary: Bovine mastitis infection in dairy cattle poses a significant economic burden globally, prompting the search for alternative treatments to reduce antibiotic usage. A novel bacteriocin, ubericin K, was discovered from a Streptococcus uberis strain in Norwegian bovine raw milk, showing potent antimicrobial activity. Whole-genome sequencing revealed a gene cluster encoding multiple bacteriocins, with ubericin K targeting bacteria causing mastitis by membrane disruption. The study suggests that ubericin K and the methodology employed could potentially aid in reducing antibiotic use in the dairy industry.

MICROBIOLOGY SPECTRUM (2021)

Article Microbiology

Identification of a Novel Two-Peptide Lantibiotic from Vagococcus fluvialis

Zuzana Rosenbergova, Thomas F. Oftedal, Kirill V. Ovchinnikov, Thasanth Thiyagarajah, Martin Rebros, Dzung B. Diep

Summary: Infections caused by multiresistant pathogens have become a major problem in both human and veterinary medicine. A novel two-peptide lantibiotic with broad-spectrum antimicrobial activity against multiresistant Enterococcus faecium has been isolated from Vagococcus fluvialis, offering potential therapeutic options.

MICROBIOLOGY SPECTRUM (2022)

Review Pharmacology & Pharmacy

Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects

Raj Kumar Thapa, Dzung B. Diep, Hanne Hjorth Tonnesen

Summary: Nanomedicine-based AMP delivery systems are a recent approach for treating bacterial infections, with advantages such as enhancing AMP stability, controlled release, and targetability. Future studies are needed to address issues like nanoparticle instability, short residence time, and toxicity. Rigorous research on AMP loaded nanoparticle preparation, characterization, in vitro and in vivo antimicrobial effects, and toxicities evaluations are essential.

JOURNAL OF PHARMACEUTICAL INVESTIGATION (2021)

暂无数据